Drugs for Aggressive Metastatic Solid Tumors
Target: matriptase
Verseon's potent novel candidates for small-molecule matriptase
inhibitors address aggressive metastatic solid-tumor cancers
TREATMENT FOR AGGRESSIVE METASTATIC CANCERS
Matriptase is a cell surface serine protease that belongs to the family by the same name. It is frequently overexpressed in many solid tumor cancers including breast, ovary, uterus, prostate, colon, cervix, and skin cancers. Higher protease activity in these tumors is correlated with more aggressive cancers. Thus a matriptase inhibitor is likely to be a potent anti-tumor drug.
Verseon has developed a series of novel small molecule inhibitors against matriptase.
9M
People die from complications arising from cancer metastasis each year
People die from complications arising from cancer metastasis each year
$36B/YEAR
Market for prevention of metastasis
Market for prevention of metastasis
VE-2843
VE-1787